Prognostic impact of nutritional status in asymptomatic patients with cardiac diseases: A report from the CHART-2 study

Circulation Journal

Volumn 77, Issue 9, 2013, Pages 2318-2326

  Nochioka, Kotaro ^a   Sakata, Yasuhiko ^a   Takahashi, Jun ^a   Miyata, Satoshi ^a   Miura, Masanobu ^a   Takada, Tsuyoshi ^a   Fukumoto, Yoshihiro ^a   Shiba, Nobuyuki ^b   Shimokawa, Hiroaki ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE   (Japan)

Author keywords

Epidemiology; Heart failure; Nutrition; Risk factors

Indexed keywords

ALBUMIN; CHOLESTEROL; HEMOGLOBIN;

AGED; ARTICLE; BODY MASS; CAUSE OF DEATH; DEATH; FEMALE; FOLLOW UP; HEART DISEASE; HEART FAILURE; HOSPITALIZATION; HUMAN; INCIDENCE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; NUTRITIONAL STATUS; SCORING SYSTEM; STAGING; SURVIVAL;

AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; HEART DISEASES; HUMANS; MALE; MIDDLE AGED; NUTRITIONAL STATUS; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SERUM ALBUMIN; SURVIVAL RATE;

EID: 84882770253     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-13-0127     Document Type: Article

References (21)

1. American Heart Association. Heart disease and stroke statistics-2012 update: A report from the American Heart Association. Circulation 2012; 125: e12-e230.
2. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, et al. ESC Committee for Practice Guidelines (CPG): ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology: Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008; 29: 2388-2442.
3. Ammar KA, Jacobsen SJ, Mahoney DW, Kors JA, Redfeld NM, Burnett JC Jr, et al. Prevalence and prognostic signifcance of heart failure stages: Application of the American College of Cardiology/ American Heart Association heart failure staging criteria in the community. Circulation 2007; 115: 1563-1570.
4. Shiba N, Nochioka K, Miura M, Kohno H, Shimokawa H; CHART-2 Investigators. Trend of westernization of etiology and clinical characteristics of heart failure patients in Japan: First report from the CHART-2 study. Circ J 2011; 75: 823-833.
5. Miura M, Shiba N, Nochioka K, Takada T, Takahashi J, Shimokawa H; CHART-2 Investigators. Urinary albumin excretion in heart failure with preserved ejection fraction: An interim analysis of the CHART 2 study. Eur J Heart Fail 2012; 14: 367-376.
6. Manabe I. Chronic infammation links cardiovascular, metabolic and renal diseases. Circ J 2011; 75: 2739-2748.
7. Anker SD, Chua TP, Ponikowski P, Harrington D, Swan JW, Kox WJ, et al. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance of cardiac cachexia. Circulation 1997; 96: 526-534.
8. Nochioka K, Shiba N, Kohno H, Miura M, Shimokawa H. Both high and low body mass indexes are prognostic risks in Japanese patients with chronic heart failure: Implications from the CHART study. J Card Fail 2010; 16: 880-887.
9. Horwich TB, Kalantar-Zadeh K, MacLellan RW, Fonarow GC. Albumin levels predict survival in patients with systolic heart failure. Am Heart J 2008; 155: 883-889.
10. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: The Framingham study. N Engl J Med 1971; 285: 1441-1446.
11. Ignacio de Ulíbarri J, González-Madroño A, de Villar NG, González P, González B, Mancha A, et al. CONUT: A tool for controlling nutritional status: First validation in a hospital population. Nutr Hosp 2005; 20: 38-45.
12. Buzby GP, Knox LS, Crosby LO, Eisenberg JM, Haakenson CM, McNeal GE, et al. Study protocol: A randomized clinical trial of total parenteral nutrition in malnourished surgical patients. Am J Clin Nutr 1988; 47: 366-381.
13. WHO scientifc group. Nutritional anemias: Report of a WHO sci-entifc group. World Health Organ Tech Rep Ser 1968; 405: 5-37.
14. National Kidney Foundation: K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classifcation and Stratif-cation. Am J Kidney Dis 2002; 39: S1-S266.
15. Velagaleti RS, Gona P, Larson MG, Wang TJ, Levy D, Benjamin EJ, et al. Multimarker approach for the prediction of heart failure incidence in the community. Circulation 2010; 122: 1700-1706.
16. Lam CS, Lyass A, Kraigher-Krainer E, Massaro JM, Lee DS, Ho JE, et al. Cardiac dysfunction and non-cardiac dysfunction as precursors of heart failure with reduced and preserved ejection fraction in the community. Circulation 2011; 124: 24-30.
17. Miura Y, Fukumoto Y, Shiba N, Miura T, Shimada K, Iwama Y, et al. Prevalence and clinical implication of metabolic syndrome in chronic heart failure. Circ J 2010; 74: 2612-2621.
18. Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG, et al. Obesity and the risk of heart failure. N Engl J Med 2002; 347: 305-313.
19. Wilson PW, D'Agostino RB, Sullivan L, Parise H, Kannel WB. Overweight and obesity as determinants of cardiovascular risk: The Framingham experience. Arch Intern Med 2002; 162: 1867-1872.
20. Kjekshus J, Apetrei E, Barrios V, Böhm M, Cleland JG, Cornel JH, et al. Rosuvastatin in older patients with systolic heart failure. N Engl J Med 2007; 357: 2248-2261.
21. Colucci WS, Kolias TJ, Adams KF, Armstrong WF, Ghali JK, Gottlieb SS, et al. Metoprolol reverses left ventricular remodeling in patients with asymptomatic systolic dysfunction: The REversal of VEntricular Remodeling with Toprol-XL (REVERT) trial. Circulation 2007; 116: 49-56.